Related Experiment Video
Updated: May 26, 2026

Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS
Published on: July 11, 2016
Stenotrophomonas maltophilia: an emerging global opportunistic pathogen
1Department of Biological Sciences, DePaul University, Chicago, Illinois, USA. jbrooke@depaul.edu
Abstract:
Stenotrophomonas maltophilia is an emerging multidrug-resistant global opportunistic pathogen. The increasing incidence of nosocomial and community-acquired S. maltophilia infections is of particular concern for immunocompromised individuals, as this bacterial pathogen is associated with a significant fatality/case ratio. S. maltophilia is an environmental bacterium found in aqueous habitats, including plant rhizospheres, animals, foods, and water sources. Infections of S. maltophilia can occur in a range of organs and tissues; the organism is commonly found in respiratory tract infections. This review summarizes the current literature and presents S. maltophilia as an organism with various molecular mechanisms used for colonization and infection. S. maltophilia can be recovered from polymicrobial infections, most notably from the respiratory tract of cystic fibrosis patients, as a cocolonizer with Pseudomonas aeruginosa. Recent evidence of cell-cell communication between these pathogens has implications for the development of novel pharmacological therapies. Animal models of S. maltophilia infection have provided useful information about the type of host immune response induced by this opportunistic pathogen. Current and emerging treatments for patients infected with S. maltophilia are discussed.
Insights
Stenotrophomonas maltophilia is a multidrug-resistant pathogen causing severe infections, especially in immunocompromised individuals. This review details its infection mechanisms, co-colonization, and treatment strategies.
Area of Science:
- Microbiology
- Infectious Diseases
- Pathogen Research
Background:
- Stenotrophomonas maltophilia is an emerging, multidrug-resistant opportunistic pathogen with increasing incidence in nosocomial and community-acquired infections.
- This bacterium is found in diverse aqueous environments and can infect various organs, frequently causing respiratory tract infections.
- It poses a significant threat to immunocompromised individuals due to a high fatality-to-case ratio.
Purpose of the Study:
- To review the current literature on Stenotrophomonas maltophilia.
- To present the molecular mechanisms of colonization and infection employed by S. maltophilia.
- To discuss S. maltophilia's role in polymicrobial infections, host immune responses, and current/emerging treatments.
Main Methods:
- Literature review of current scientific publications.
- Analysis of molecular mechanisms for colonization and infection.
- Examination of S. maltophilia's role in polymicrobial infections, including co-colonization with Pseudomonas aeruginosa.
- Review of findings from animal models regarding host immune response.
- Synthesis of information on current and emerging therapeutic strategies.
Main Results:
- S. maltophilia utilizes various molecular mechanisms for colonization and infection.
- It is a common co-colonizer, particularly with Pseudomonas aeruginosa in cystic fibrosis patients' respiratory tracts.
- Cell-cell communication between S. maltophilia and P. aeruginosa has therapeutic implications.
- Animal models reveal insights into the host immune response to S. maltophilia infections.
Conclusions:
- Stenotrophomonas maltophilia is a significant opportunistic pathogen requiring further research into its virulence factors and treatment.
- Understanding pathogen interactions, like co-colonization with P. aeruginosa, is crucial for developing novel therapies.
- Effective management strategies for S. maltophilia infections involve a comprehensive approach considering its environmental origins, molecular mechanisms, and host interactions.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Fungal Phylum Microsporidia
Clinical Significance of Antibiotic Resistance
Atypical Pneumonia
Fungal Group Zygomycota
